Projects funded by the NCN
Pharmacogenomics of SGLT2 inhibitors - investigating the role of empagliflozin in epigenetic modification of non-coding RNA - sirtuin - Sodium-glucose cotransporter-2 axis after myocardial infarction
2022/45/N/NZ7/02461
Keywords:
sirtuins non-coding RNAs myocardial infarction heart failure empagliflozin SGLT2 inhibitors
Descriptors:
- NZ7_012:
- NZ7_014:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Warszawski Uniwersytet Medyczny
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 208 866 PLN
Project start date (Y-m-d): 2023-02-15
Project end date (Y-m-d): 2026-02-14
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.